IgG Antibody Responses Across 3 Doses of mRNA Vaccines

July 21, 2022

study published in the Journal of Autoimmunity evaluated the immune response of Pfizer and Moderna’s mRNA COVID-19 vaccines in participants with autoimmune systemic diseases. Diseases included rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and cryoglobulinemic vasculitis.

In total, serum samples from 244 AD patients were collected 2-4 weeks and six months after their first vaccine cycle, and 2-4 weeks following their booster dose; 502 people from the general population were used as a control group. 93.7% and 6.3% in the AD cohort were vaccinated with the Pfizer and Moderna COVID-19 vaccines, respectively; this was comparable in the control group.

“Significantly lower levels of [neutralizing antibodies] were observed in the whole patients’ series and in the single [AD] subgroups at both time 1 and time 2, compared to the control group.” That being said, serum samples showed a sharp increase in antibodies after the booster dose, and the percentage of patients with no or suboptimal responses decreased significantly between the first and second check-in versus after the booster dose (from from approximately 28% to 46% – a significant rise in absent/ suboptimal response – down to approximately 8%). “The percentage of patients with absent/suboptimal response after the booster dose was significantly higher compared to controls,” which hovered at 0.2%. This was especially true for patients on immune-modifying drugs, including Rituximab, and glucocorticoids.

“The percentage of [AD] patients reporting one or more side effects within four weeks after booster administration was 40%; the side effects were usually mild and transitory. Remarkably, [AD] reactivation following the booster shot was observed in only 2% of cases although the events were invariably self-limiting.” 





Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.